EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1 H ‐ MRS Study

Alexander Gussew iD, Maryam Kargaran, Maik Rothe, Andreas Deistung iD, Dietrich Stoevesandt, Walter A Wohlgemuth, David Strube, Thomas Kendzierski, Anna Katharina Kölsch, Maurits Gerhard Abraham Heuschen, Markus Otto, Alexander Mensch iD

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Alexander Gussew und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic and Outpatient Clinic for Radiology, University Hospital Halle (Saale), Halle (Saale), Germany. Hauptthemen laut MEDLINE: Carnosine, Myotonic Dystrophy, Quadriceps Muscle. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias. A hallmark feature is the selective degeneration of type‐II fibers, likely driven by chronic myotonia and sustained metabolic stress. In this study, proton magnetic resonance spectroscopy ( 1 H‐MRS) was applied to assess intramuscular carnosine as a potential noninvasive marker of type‐II fiber integrity, alongside extramyocellular lipids (EMCL) and intracellular pH. We hypothesized that carnosine would be reduced in PROMM as a consequence of type‐II fiber loss.

Methods

Seventy participants (27 genetically confirmed PROMM patients, 43 healthy volunteers) underwent localized 1 H‐MRS of the quadriceps muscle at 3 T using a short‐TE PRESS sequence. To ensure reliable carnosine quantification, spectra with voxel fat fraction ≥ 40% were excluded, yielding a final cohort of 19 patients and 19 matched healthy volunteers. Metabolites were quantified relative to total creatine, and exploratory correlations were assessed.

Results

PROMM patients showed significantly reduced carnosine compared with healthy volunteers (−50%, 0.05 ± 0.03 vs. 0.10 ± 0.05; p = 0.0022) and markedly elevated EMCL (threefold, 150.6 ± 80.5 vs. 48.6 ± 38.4; p = 0.0007). Intracellular pH did not differ between groups. Exploratory analysis revealed a negative correlation between carnosine and EMCL ( r = −0.50, p = 0.03).

Interpretation

This pilot study demonstrates that 1 H‐MRS can detect reduced intramuscular carnosine in PROMM, consistent with selective type‐II‐fiber loss. Carnosine thus emerges as a potential in vivo biomarker of fiber‐type‐specific degeneration. Validation in larger, longitudinal cohorts is warranted to establish its clinical and translational relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnosineMyotonic DystrophyQuadriceps MuscleHumansMaleFemaleMiddle AgedPilot ProjectsAdultProton Magnetic Resonance SpectroscopyAged

Stichwörter der Autor:innen

1H‐MR spectroscopyPROMMcarnosinemusclemyotonic dystrophy type 2

Substanzen

Carnosine

Autor:innen und Institutionen

  • University Clinic and Outpatient Clinic for Radiology, University Hospital Halle (Saale), Halle (Saale), Germany.
  • Halle MR Imaging Core Facility, University Medicine Halle (Saale), Halle (Saale), Germany.
  • University Clinic and Outpatient Clinic for Neurology, University Medicine Halle (Saale), Halle (Saale), Germany.
  • Heimer Institute for Muscle Research, Bochum, Germany.

ORCID-Profile: Alexander Gussew, Andreas Deistung, Alexander Mensch

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Gussew, A., Kargaran, M., Rothe, M., Deistung, A., Stoevesandt, D., Wohlgemuth, W. A., Strube, D., Kendzierski, T., Kölsch, A. K., Heuschen, M. G. A., Otto, M., & Mensch, A. (2025). Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1 H ‐ MRS Study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70263

Vancouver

Gussew A, Kargaran M, Rothe M, Deistung A, Stoevesandt D, Wohlgemuth WA, et al. Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1 H ‐ MRS Study. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70263

BibTeX
@article{Gussew2025,
  author = {Gussew, Alexander and Kargaran, Maryam and Rothe, Maik and Deistung, Andreas and Stoevesandt, Dietrich and Wohlgemuth, Walter A and Strube, David and Kendzierski, Thomas and Kölsch, Anna Katharina and Heuschen, Maurits Gerhard Abraham and Otto, Markus and Mensch, Alexander},
  title = {Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1 H ‐ MRS Study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70263}
}
Kostenlos starten →